5-[(Cyclopropylamino)methyl]-2,3-dimethylbenzene-1-sulfonamide hydrochloride

Catalog No.: 
ACHYBF131
CAS No.: 
1955524-11-4
Molecular Formula: 
C12H19ClN2O2S
Molecular Weight: 
290.82
5-[(Cyclopropylamino)methyl]-2,3-dimethylbenzene-1-sulfonamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$279.00InquiryInquiry
100mg95%$406.00InquiryInquiry
250mg95%$892.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-[(Cyclopropylamino)methyl]-2,3-dimethylbenzene-1-sulfonamide hydrochloride
IUPAC Name5-((cyclopropylamino)methyl)-2,3-dimethylbenzenesulfonamide hydrochloride
MDL No.0
Molecular FormulaC12H19ClN2O2S
Molecular Weight290.82
SMILESO=S(C1=CC(CNC2CC2)=CC(C)=C1C)(N)=O.[H]Cl
InChI KeyGOTPKDFAGYEBPH-UHFFFAOYSA-N
Synonym5-[(cyclopropylamino)methyl]-2,3-dimethylbenzene-1-sulfonamide hydrochloride
CAS No.1955524-11-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACHYBF131 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0In Stock
  4. Then
  5. ACHYBF131 route product structure diagram
    ACHYBF1311955524-11-4
Inquiry

2. ACHYBF131 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHYBF131 route product structure diagram
    ACHYBF1311955524-11-4
Inquiry

3. ACHYBF131 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHYBF131 route product structure diagram
    ACHYBF1311955524-11-4
Inquiry

Comments (0)